Difficulty: Medium
Average Score: 73%
Practice
The most dangerous pharmacodynamic interaction is between MAO inhibitors and:
Correct answer
C
Rationale
In the context of Safety Pharmacology Across the Lifespan, understanding potentially dangerous pharmacodynamic interactions is crucial to ensuring patient safety. In this case, the correct answer is C) Sympathomimetics.
MAO inhibitors work by inhibiting the enzyme monoamine oxidase, which can lead to an accumulation of certain neurotransmitters like norepinephrine and dopamine. When combined with sympathomimetics, which are drugs that mimic the effects of the sympathetic nervous system (e.g., drugs used for decongestion or asthma), there is a risk of excessive stimulation of the sympathetic nervous system. This can result in a dangerous increase in blood pressure, heart rate, and potential arrhythmias, leading to serious cardiovascular complications.
Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants are not typically associated with the same level of risk when combined with MAO inhibitors. While there are potential interactions to be aware of, they do not pose the same immediate life-threatening dangers as the combination with sympathomimetics.
Educationally, this question highlights the importance of understanding specific drug interactions, especially those that can have severe consequences such as cardiovascular complications. Healthcare providers must be vigilant in assessing a patient's complete medication regimen to avoid potentially harmful interactions and ensure patient safety across all age groups.
MAO inhibitors work by inhibiting the enzyme monoamine oxidase, which can lead to an accumulation of certain neurotransmitters like norepinephrine and dopamine. When combined with sympathomimetics, which are drugs that mimic the effects of the sympathetic nervous system (e.g., drugs used for decongestion or asthma), there is a risk of excessive stimulation of the sympathetic nervous system. This can result in a dangerous increase in blood pressure, heart rate, and potential arrhythmias, leading to serious cardiovascular complications.
Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants are not typically associated with the same level of risk when combined with MAO inhibitors. While there are potential interactions to be aware of, they do not pose the same immediate life-threatening dangers as the combination with sympathomimetics.
Educationally, this question highlights the importance of understanding specific drug interactions, especially those that can have severe consequences such as cardiovascular complications. Healthcare providers must be vigilant in assessing a patient's complete medication regimen to avoid potentially harmful interactions and ensure patient safety across all age groups.